Navigation Links
Draeger Announces Partnership With L. N. Curtis & sons to Distribute Emergency Responder Equipment
Date:7/15/2010

PITTSBURGH, July 15 /PRNewswire/ -- Draeger Safety Inc. announced today that L. N. Curtis & sons will be a new distributor of Draeger emergency responder equipment in thirteen western states in the United States.

As a non-exclusive primary distributor, L. N. Curtis & sons will handle sales, delivery and service for all Draeger products sold to state and local municipal fire departments and law enforcement responders, and to U.S. Federal Forest Services in the Western United States.  L. N. Curtis & sons has sales, distribution and services centers located in Oakland, California; Salt Lake City, Utah; Seattle, Washington; Los Angeles, California; and Phoenix, Arizona.      

Formed in 1929, L. N. Curtis & sons has a long history and an outstanding reputation as a distributor of emergency responder and firefighting equipment.  "Known for their professional people and excellent customer service, L. N. Curtis is a distinguished leader in its field," said Scott Miller, Western Division Sales Manager, Draeger Safety Inc. "Priding ourselves on the highest quality products and service, this distributorship provides important benefits for our customers and will offer significant opportunities for both companies."

Draeger offers a wide range of proven and innovative products for fire and emergency services with a focus on personal safety and hazard management.

Draeger. Technology for Life®

Draeger is an international leader in the fields of medical and safety technology. Draeger products protect, support and save lives. Founded in 1889, in 2009 Draeger generated revenues of around EUR 1.9 billion. The Draeger Group is currently present in more than 190 countries and has about 11,000 employees worldwide. Please visit www.draeger.com for more information.


'/>"/>
SOURCE Draeger
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Draeger Donating Mechanical Ventilators and Anesthesia Machines to University of Miami - Aid for Haiti Earthquake Disaster
2. Draeger Infinity M300 Patient-Worn Monitors Help Improve Patient Care at Kaweah Delta Medical Center
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... Dec. 5, 2016   Mallinckrodt Pharmaceuticals (NYSE: ... company, today announced that it received a perfect score ... (CEI), a national benchmarking survey and report on corporate ... transgender (LGBT) workplace equality, administered by the Human Rights ... major U.S. businesses which also earned top marks this ...
(Date:12/5/2016)... , Dec. 5, 2016 Special purpose needles are ... such as fluid and cells from organs or lumps and ... and sizes. The global market for special purpose needles is ... In terms of revenue, the global special purpose needles market ... the forecast period (2016–2026) and is expected to be valued ...
(Date:12/5/2016)...   Lexicon Pharmaceuticals, Inc. (Nasdaq: ... 2 clinical study of sotagliflozin, a dual SGLT1 and ... the leading global organization funding type 1 diabetes research. ... trial, which randomized a total of 87 patients, was ... dose of sotagliflozin compared to a placebo control in ...
Breaking Medicine Technology:
(Date:12/5/2016)... , ... December 05, 2016 , ... ... Plastic Surgery, is excited to announce the arrival of the newest Sciton laser ... with the ability to use tunable non-ablative and ablative wavelengths for exceptional results. ...
(Date:12/5/2016)... ... December 05, 2016 , ... SyncDog, Inc., the leading ... magazine, a leading online tech news platform connecting technology innovators with news, experience, ... explores the state of enterprise mobility security today, and how the SyncDog SentinelSecure™ ...
(Date:12/5/2016)... ... 05, 2016 , ... Worldwise ®, a leading consumer ... kathy ireland® Worldwide for five additional years, announced by Kevin Fick, Worldwise CEO. ... agreement three years ago to design and develop the kathy ireland® Loved Ones™ ...
(Date:12/5/2016)... ... December 05, 2016 , ... Physicians Education Resource®, ... International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma, on February ... are honored to have Amy E. Herman present at this year’s conference, her ...
(Date:12/5/2016)... , ... December 05, 2016 , ... BSI and Brenntag ... United States and Canada for distribution of their natural fruits and beverage ... is an exciting addition to our Life Sciences product portfolio,” said Steve Brauer, ...
Breaking Medicine News(10 mins):